News and Trends 7 Dec 2022
Apogee Therapeutics raises $169M to tackle immunological and inflammatory disorders
Apogee Therapeutics, LLC, a biotech company advancing novel, potentially best-in-class therapies to address immunological and inflammatory disorders, has announced the…